The International Regulatory Affairs Network
12.03.2010
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the 22nd Annual ROTH Growth Stock Conference on Tuesday, March 16, 2010 at 10:30 a.m. PDT (1:30 p.m. EDT) and at the Barclays Capital 2010 Global Healthcare Conference on Tuesday, March 23, 2010 at 3:15 p.m. EDT.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the 22nd Annual ROTH Growth Stock Conference on Tuesday, March 16, 2010 at 10:30 a.m. PDT (1:30 p.m. EDT) and at the Barclays Capital 2010 Global Healthcare Conference on Tuesday, March 23, 2010 at 3:15 p.m. EDT.
The presentations will be webcast live and may be accessed from ‘Events & Presentations' on the home page of Vertex's website at www.vrtx.com. A replay of the webcasts will also be available on the Company's website for two weeks following each presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, epilepsy, cancer, and pain. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex's press releases are available at www.vrtx.com.
(VRTX-WEB)
Farmavita.Net
